Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome

References

1. 1.↵
   2. Dalmau J,
   3. Erdem T,
   4. Wu H-y, et al

   . Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25–36 doi:10.1002/ana.21050

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Dalmau J,
   3. Lancaster E,
   4. Martinez-Hernandez E, et al

   . Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63–74 doi:10.1016/S1474-4422(10)70253-2 pmid:21163445

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Viaccoz A,
   3. Desestret V,
   4. Ducray F, et al

   . Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 2014;82:556–63 doi:10.1212/WNL.0000000000000126 pmid:24443452

   CrossRefPubMed
4. 4.↵
   2. Jones KC,
   3. Benseler SM,
   4. Moharir M

   . Anti–NMDA receptor encephalitis. Neuroimaging Clin N Am 2013;23:309–20 doi:10.1016/j.nic.2012.12.009 pmid:23608692

   CrossRefPubMed
5. 5.↵
   2. Finke C,
   3. Kopp UA,
   4. Prüss H, et al

   . Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2012;83:195–98 doi:10.1136/jnnp-2011-300411 pmid:21933952

   Abstract/FREE Full Text
6. 6.↵
   2. Gultekin SH,
   3. Rosenfeld MR,
   4. Voltz R, et al

   . Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123:1481–94 doi:10.1093/brain/123.7.1481 pmid:10869059

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Titulaer MJ,
   3. McCracken L,
   4. Gabilondo I, et al

   . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–65 doi:10.1016/S1474-4422(12)70310-1 pmid:23290630

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Irani SR,
   3. Bera K,
   4. Waters P, et al

   . N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655–67 doi:10.1093/brain/awq113 pmid:20511282

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Dalmau J,
   3. Gleichman AJ,
   4. Hughes EG, et al

   . Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–98 doi:10.1016/S1474-4422(08)70224-2 pmid:18851928

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Greiner H,
    3. Leach JL,
    4. Lee KH, et al

    . Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 2011;20:266–70 doi:10.1016/j.seizure.2010.11.013 pmid:21146427

    CrossRefPubMed
11. 11.↵
    2. Günther A,
    3. Brodoehl S,
    4. Witte OW, et al

    . Atypical posthypoxic MRI changes in hypermetabolic regions in anti-NMDA-receptor encephalitis. Neurology 2012;79:720–21 doi:10.1212/WNL.0b013e3182648bdc pmid:22891114

    FREE Full Text
12. 12.↵
    2. Hoffmann LA,
    3. Jarius S,
    4. Pellkofer HL, et al

    . Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 2008;79:767–73 doi:10.1136/jnnp.2007.118588

    Abstract/FREE Full Text
13. 13.↵
    2. Haberlandt E,
    3. Bast T,
    4. Ebner A, et al

    . Limbic encephalitis in children and adolescents. Arch Dis Child 2011;96:186–91 doi:10.1136/adc.2010.183897 pmid:20959359

    Abstract/FREE Full Text
14. 14.↵
    2. Iizuka T,
    3. Yoshii S,
    4. Kan S, et al

    . Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 2010;257:1686–91 doi:10.1007/s00415-010-5604-6 pmid:20517615

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Wahlund LO,
    3. Julin P,
    4. Johansson SE, et al

    . Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 2000;69:630–35 doi:10.1136/jnnp.69.5.630 pmid:11032615

    Abstract/FREE Full Text
16. 16.↵
    2. Bresciani L,
    3. Rossi R,
    4. Testa C, et al

    . Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry. Aging Clin Exp Res 2005;17:8–13 doi:10.1007/BF03337714 pmid:15847116

    CrossRefPubMed
17. 17.↵
    2. van Swieten JC,
    3. Koudstaal PJ,
    4. Visser MC, et al

    . Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–07 doi:10.1161/01.STR.19.5.604 pmid:3363593

    Abstract/FREE Full Text
18. 18.↵
    2. Peery HE,
    3. Day GS,
    4. Dunn S, et al

    . Anti-NMDA receptor encephalitis: the disorder, the diagnosis and the immunobiology. Autoimmun Rev 2012;11:863–72 doi:10.1016/j.autrev.2012.03.001 pmid:22440397

    CrossRefPubMed
19. 19.↵
    2. Maneta E,
    3. Garcia G

    . Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications. Psychosomatics 2014;55:37–44 doi:10.1016/j.psym.2013.06.002 pmid:23932531

    CrossRefPubMed
20. 20.↵
    2. Sansing LH,
    3. Tüzün E,
    4. Ko MW, et al

    . A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007;3:291–96 doi:10.1038/ncpneuro0493 pmid:17479076

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Parratt KL,
    3. Allan M,
    4. Lewis SJ, et al

    . Acute psychiatric illness in a young woman: an unusual form of encephalitis. Med J Aust 2009;191:284–86 pmid:19740054

    PubMedWeb of Science
22. 22.↵
    2. Florance NR,
    3. Davis RL,
    4. Lam C, et al

    . Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11–18 doi:10.1002/ana.21756 pmid:19670433

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Lin JJ,
    3. Lin KL,
    4. Hsia SH, et al

    ; Children with Encephalitis and/or Encephalopathy Related Status Epilepticus and Epilepsy (CHEESE) Study Group. Anti-N-methyl-D-aspartate receptor encephalitis in Taiwan: a comparison between children and adults. Pediatr Neurol 2014;50:574–80 doi:10.1016/j.pediatrneurol.2014.01.049 pmid:24739379

    CrossRefPubMed
24. 24.↵
    2. Gabilondo I,
    3. Saiz A,
    4. Galán L, et al

    . Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011;77:996–99 doi:10.1212/WNL.0b013e31822cfc6b pmid:21865579

    Abstract/FREE Full Text
25. 25.↵
    2. Finke C,
    3. Kopp UA,
    4. Scheel M, et al

    . Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2013;74:284–96 doi:10.1002/ana.23932 pmid:23686722

    CrossRefPubMed
26. 26.↵
    2. Finke C,
    3. Kopp UA,
    4. Pajkert A, et al

    . Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis. Biol Psychiatry 2016;79:727–34 doi:10.1016/j.biopsych.2015.02.024 pmid:25866294

    CrossRefPubMed
27. 27.↵
    2. Gresa-Arribas N,
    3. Titulaer MJ,
    4. Torrents A, et al

    . Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014;13:167–77 doi:10.1016/S1474-4422(13)70282-5 pmid:24360484

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Baumgartner A,
    3. Rauer S,
    4. Mader I, et al

    . Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 2013;260:2744–53 doi:10.1007/s00415-013-7048-2 pmid:23900756

    CrossRefPubMed
29. 29.↵
    2. Peer M,
    3. Prüss H,
    4. Ben-Dayan I, et al

    . Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry 2017;4:768–74 doi:10.1016/S2215-0366(17)30330-9 pmid:28882707

    CrossRefPubMed